Gene Review:
nef - p27
Human immunodeficiency virus 1
Husain,
Gusella,
Klotman,
Gelman,
Ross,
Schwartz,
Cara,
Klotman,
Berkhout,
Verhoef,
van Wamel,
Back,
Tähtinen,
Strengell,
Collings,
Pitkänen,
Kjerrström,
Hakkarainen,
Peterson,
Kohleisen,
Wahren,
Ranki,
Ustav,
Krohn,
Simon,
Mauclère,
Roques,
Loussert-Ajaka,
Müller-Trutwin,
Saragosti,
Georges-Courbot,
Barré-Sinoussi,
Brun-Vézinet,
Graham,
Koup,
Roederer,
Bailer,
Enama,
Moodie,
Martin,
McCluskey,
Chakrabarti,
Lamoreaux,
Andrews,
Gomez,
Mascola,
Nabel,
Drakesmith,
Chen,
Ledermann,
Screaton,
Townsend,
Xu,
Noel,
Toro-Bahamonde,
Marrero-Otero,
Orsini,
Verma,
Kumar,
Kumar,
Hel,
Johnson,
Tryniszewska,
Tsai,
Harrod,
Fullen,
Tartaglia,
Franchini,
Yang,
Nguyen,
Kalams,
Dorfman,
Göttlinger,
Stewart,
Chen,
Threlkeld,
Walker,
- Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Simon, F., Mauclère, P., Roques, P., Loussert-Ajaka, I., Müller-Trutwin, M.C., Saragosti, S., Georges-Courbot, M.C., Barré-Sinoussi, F., Brun-Vézinet, F. Nat. Med. (1998)
- Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Wu, Y., Marsh, J.W. Science (2001)
- Entire Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env. Calugi, G., Montella, F., Favalli, C., Benedetto, A. J. Virol. (2006)
- Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. Wildum, S., Schindler, M., Münch, J., Kirchhoff, F. J. Virol. (2006)
- A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Hel, Z., Johnson, J.M., Tryniszewska, E., Tsai, W.P., Harrod, R., Fullen, J., Tartaglia, J., Franchini, G. Vaccine (2002)
- CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable. Agopian, K., Wei, B.L., Garcia, J.V., Gabuzda, D. Virology (2007)
- Lack of correlation between SIV-Nef evolution and rapid disease progression in morphine-dependent nonhuman primate model of AIDS. Noel, R.J., Toro-Bahamonde, A., Marrero-Otero, Z., Orsini, S., Verma, A.S., Kumar, R., Kumar, A. AIDS Res. Hum. Retroviruses (2006)
- Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism. Qi, M., Aiken, C. J. Virol. (2007)
- Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex. McPhee, D.A., Greenway, A.L., Holloway, G., Smith, K., Deacon, N., Pemberton, L., Brew, B.J. J. Neurovirol. (1998)
- Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Schindler, M., Münch, J., Kutsch, O., Li, H., Santiago, M.L., Bibollet-Ruche, F., Müller-Trutwin, M.C., Novembre, F.J., Peeters, M., Courgnaud, V., Bailes, E., Roques, P., Sodora, D.L., Silvestri, G., Sharp, P.M., Hahn, B.H., Kirchhoff, F. Cell (2006)
- HIV pathogenesis: Nef loses control. Foster, J.L., Garcia, J.V. Cell (2006)
- HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Witte, V., Laffert, B., Rosorius, O., Lischka, P., Blume, K., Galler, G., Stilper, A., Willbold, D., D'Aloja, P., Sixt, M., Kolanus, J., Ott, M., Kolanus, W., Schuler, G., Baur, A.S. Mol. Cell (2004)
- Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif. Coleman, S.H., Madrid, R., Van Damme, N., Mitchell, R.S., Bouchet, J., Servant, C., Pillai, S., Benichou, S., Guatelli, J.C. J. Virol. (2006)
- HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor. Vigerust, D.J., Egan, B.S., Shepherd, V.L. J. Leukoc. Biol. (2005)
- Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. Bachelerie, F., Alcami, J., Hazan, U., Israël, N., Goud, B., Arenzana-Seisdedos, F., Virelizier, J.L. J. Virol. (1990)
- Epitopes of human immunodeficiency virus regulatory proteins tat, nef and rev are expressed in skin in atopic dermatitis. Schuurman, H.J., Joling, P., van Wichen, D.F., Tobin, D., van der Putte, S.C. Int. Arch. Allergy Immunol. (1993)
- HIV-1 Genes vpr and nef Synergistically Damage Podocytes, Leading to Glomerulosclerosis. Zuo, Y., Matsusaka, T., Zhong, J., Ma, J., Ma, L.J., Hanna, Z., Jolicoeur, P., Fogo, A.B., Ichikawa, I. J. Am. Soc. Nephrol. (2006)
- HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. Husain, M., Gusella, G.L., Klotman, M.E., Gelman, I.H., Ross, M.D., Schwartz, E.J., Cara, A., Klotman, P.E. J. Am. Soc. Nephrol. (2002)
- Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. Michael, N.L., Chang, G., d'Arcy, L.A., Ehrenberg, P.K., Mariani, R., Busch, M.P., Birx, D.L., Schwartz, D.H. J. Virol. (1995)
- Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. Berkhout, B., Verhoef, K., van Wamel, J.L., Back, N.K. J. Virol. (1999)
- Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development. Stove, V., Naessens, E., Stove, C., Swigut, T., Plum, J., Verhasselt, B. Blood (2003)
- Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Gruber, A., Kan-Mitchell, J., Kuhen, K.L., Mukai, T., Wong-Staal, F. Blood (2000)
- Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo. Rücker, E., Grivel, J.C., Münch, J., Kirchhoff, F., Margolis, L. J. Virol. (2004)
- HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Drakesmith, H., Chen, N., Ledermann, H., Screaton, G., Townsend, A., Xu, X.N. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. Madrid, R., Janvier, K., Hitchin, D., Day, J., Coleman, S., Noviello, C., Bouchet, J., Benmerah, A., Guatelli, J., Benichou, S. J. Biol. Chem. (2005)
- HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. Janvier, K., Craig, H., Hitchin, D., Madrid, R., Sol-Foulon, N., Renault, L., Cherfils, J., Cassel, D., Benichou, S., Guatelli, J. J. Biol. Chem. (2003)
- Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. Williams, M., Roeth, J.F., Kasper, M.R., Filzen, T.M., Collins, K.L. J. Virol. (2005)
- Human immunodeficiency virus-1 Nef protein interacts with Tat and enhances HIV-1 gene expression. Joseph, A.M., Ladha, J.S., Mojamdar, M., Mitra, D. FEBS Lett. (2003)
- Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. Garcia, J.V., Miller, A.D. AIDS Res. Hum. Retroviruses (1994)
- Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20). Lu, J., Sista, P., Giguel, F., Greenberg, M., Kuritzkes, D.R. J. Virol. (2004)
- Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. Swanson, A.K., Stoltzfus, C.M. J. Biol. Chem. (1998)
- Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes. Ayyavoo, V., Kudchodkar, S., Ramanathan, M.P., Le, P., Muthumani, K., Megalai, N.M., Dentchev, T., Santiago-Barrios, L., Mrinalini, C., Weiner, D.B. AIDS (2000)
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine. Graham, B.S., Koup, R.A., Roederer, M., Bailer, R.T., Enama, M.E., Moodie, Z., Martin, J.E., McCluskey, M.M., Chakrabarti, B.K., Lamoreaux, L., Andrews, C.A., Gomez, P.L., Mascola, J.R., Nabel, G.J. J. Infect. Dis. (2006)
- Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. Yang, O.O., Nguyen, P.T., Kalams, S.A., Dorfman, T., Göttlinger, H.G., Stewart, S., Chen, I.S., Threlkeld, S., Walker, B.D. J. Virol. (2002)
- DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector. Tähtinen, M., Strengell, M., Collings, A., Pitkänen, J., Kjerrström, A., Hakkarainen, K., Peterson, P., Kohleisen, B., Wahren, B., Ranki, A., Ustav, M., Krohn, K. Vaccine (2001)
- HIV-1 Nef promotes survival of TF-1 macrophages by inducing Bcl-XL expression in an extracellular signal-regulated kinase-dependent manner. Choi, H.J., Smithgall, T.E. J. Biol. Chem. (2004)
- Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E., Krohn, K.J. Arch. Virol. (1994)
- Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. Nishino, Y., Nakaya, T., Fujinaga, K., Kishi, M., Azuma, I., Ikuta, K. J. Gen. Virol. (1994)